Chronic Urinary Tract Infection: Symptoms, Causes, Tests, Treatment

Chronic urinary tract infection is one of the most common conditions affecting the urinary system, particularly in women. Recurrent or chronic UTI is defined as the occurrence of repeated episodes of urinary tract infection, usually more than two episodes within six months or more than three within one year. Despite its high prevalence, disease management is often limited to treating symptoms, without thoroughly investigating the underlying mechanisms.

The modern approach, especially through the lens of functional medicine, seeks to highlight the deeper causes that promote persistence or recurrence of infection. Understanding these mechanisms allows for a more targeted and personalized strategy for prevention and treatment.

Epidemiological Data

Urinary tract infections are among the most common bacterial infections in humans. It is estimated that up to 50–60 percent of women will experience at least one episode during their lifetime, while a significant proportion of them will develop recurrent infections.

In Europe, the annual incidence of Urinary tract infections (UTIs) is estimated at millions of cases, placing a considerable burden on healthcare systems. In Greece, although epidemiological data are limited, clinical experience and records indicate a high frequency, particularly among women of reproductive age and postmenopausal women.

Certain groups present an increased risk of developing chronic urinary tract infection:

• Women, due to urethral anatomy, as the shorter distance from the anus facilitates bacterial transfer. This is a key factor explaining the higher incidence in women.
• Individuals with diabetes mellitus, as hyperglycemia promotes microbial growth and affects immune response.
• Elderly patients, due to weakened immunity and frequent comorbidities.
• Individuals with catheters or anatomical abnormalities of the urinary tract.

Symptoms and Signs

Chronic urinary tract infection can present with a variety of symptoms, which often recur or persist despite treatment. The clinical picture depends on the part of the urinary tract affected and the severity of the infection.

The most common symptoms include:

• Dysuria, meaning pain or a burning sensation during urination. This symptom results from irritation of the urothelium by bacteria.
• Urinary frequency and urgency, where patients feel the need to urinate at short intervals, even when the bladder is not full.
• A sensation of incomplete bladder emptying, associated with inflammation or dysfunction of the bladder.
• Cloudy or foul-smelling urine, indicating the presence of bacteria and inflammatory cells.
• Hematuria, meaning the presence of blood in the urine, which may be microscopic or visible.
• Pain in the suprapubic region or lower back, particularly when the kidneys are involved.

In chronic cases, symptoms may be milder but persistent, making diagnosis more challenging and significantly affecting quality of life.

Underlying Causes

Chronic urinary tract infection is not simply the result of repeated exposure to pathogenic microbes but is associated with a range of factors that influence microbial balance, immune defense, and urinary tract function. Functional medicine focuses on identifying these underlying causes, aiming for a more fundamental rather than purely symptomatic approach.

Disruption of the gut, urinary, and vaginal microbiome. The microbiome plays a crucial role in defense against pathogenic microorganisms. Disruption of the balance of beneficial bacteria, particularly in the gut and vagina, can allow the overgrowth of pathogens such as Escherichia coli. The use of antibiotics, poor diet, and chronic stress significantly contribute to this dysbiosis. The transfer of bacteria from the gut to the urinary tract is a key mechanism in recurrent infections.

Impaired immune response. Effective immune system function is essential for clearing microbes. Factors such as deficiencies in essential micronutrients, chronic inflammation, and hormonal imbalances can reduce immune competence. In such cases, even a low microbial load may lead to persistent infections.

Hormonal changes. Estrogens directly influence the health of the urogenital system, as they help maintain normal flora and epithelial integrity. During periods such as menopause, decreased estrogen levels increase susceptibility to infections. Hormonal imbalance may also affect pH and promote pathogen growth.

Antibiotic resistance and microbial biofilms. In many cases of chronic urinary tract infections, bacteria form biofilms; protective structures that make them resistant to antibiotics. This results in persistence of infection despite pharmacological treatment. Excessive or inappropriate use of antibiotics further enhances antimicrobial resistance.

Anatomical and functional factors. Abnormalities in the urinary tract, such as urinary reflux or incomplete bladder emptying, create an environment favorable for microbial growth. Additionally, conditions such as neurogenic bladder or the presence of stones contribute to chronic inflammation and recurrence.

Laboratory Tests for Disease Investigation

The evaluation of chronic urinary tract infection requires a multifactorial approach, not limited to identifying the pathogenic microorganism. Modern diagnostic practice combines conventional tests with more specialized functional medicine analyses to reveal underlying causes and predisposing factors.

(a) Conventional laboratory tests
Basic tests constitute the first step in confirming infection and assessing the initial clinical condition.

• Urinalysis: Provides information on the presence of leukocytes, nitrites, hemoglobin, and bacteria. It is the simplest and most immediate test for detecting inflammation in the urinary tract.
• Urine culture with antibiogram: Allows identification of the microorganism and selection of the appropriate antibiotic. It is critical in cases of recurrent infections.
• Complete blood count (CBC): Evaluates inflammatory markers such as white blood cells and may indicate systemic response.
• CRP (C-reactive protein): A marker of acute inflammation, useful for assessing infection severity.
• Urea and creatinine: Assess kidney function, particularly important when upper UTI or complications are suspected.
• Blood glucose and glycosylated hemoglobin (HbA1c): Evaluate for diabetes mellitus, a significant risk factor for chronic infections.
   

(b) Functional Medicine Tests
Functional medicine testing aims to identify deeper causes contributing to recurrent UTIs and forms a key tool for personalized approaches.

• EnteroScan® (Gut Microbiome Analysis): Evaluates the composition and balance of intestinal bacteria. Dysbiosis is directly linked to UTIs, as pathogenic bacteria may migrate to the urinary tract. This test helps identify harmful microbial overgrowth and guide personalized interventions.
• MetaBolomiX™ (Urinary Organic Acids Test): Provides information about metabolism, mitochondrial function, and microbial overgrowth. It may reveal signs of fungal or bacterial dysbiosis not detected by conventional tests.
• NutriScan® (Nutrient Deficiency Assessment): Evaluates essential nutrients required for proper immune function. Deficiencies may be associated with increased susceptibility to infections.
• HormoneScan® (Hormonal Assessment): Particularly important in women, as hormonal imbalances affect the natural defense of the urogenital system. This test helps identify imbalances that promote infections.
• ImmuneScan® (Immune System Evaluation): Assesses levels of systemic or chronic inflammation. Prolonged inflammatory activity may negatively impact immune response and contribute to persistent or recurrent infections.
• DetoxScan® (Oxidative Stress Assessment): Reflects the balance between free radicals and antioxidant mechanisms. Increased oxidative stress is associated with cellular damage and immune dysfunction, increasing vulnerability to chronic infections.
   

(c) Additional (imaging) tests

• Ultrasound of kidneys and bladder: Imaging to detect anatomical abnormalities or stones.
• Abdominal CT scan: Detailed imaging for complications or chronic inflammation.
• Cystoscopy: Endoscopic examination of the bladder for direct evaluation of the mucosa.

Therapeutic Approaches

Management of chronic urinary tract infection requires a combination of strategies targeting both eradication of the pathogen and correction of underlying dysfunctions that promote recurrence. A comprehensive approach includes conventional medical treatments as well as natural interventions that support overall health.

(a) Conventional treatments
The main therapeutic approach involves antibiotics, selected based on the antibiogram. In acute infections, treatment is usually short-term, while in chronic or recurrent cases, prolonged or prophylactic administration may be required.

Commonly used antibiotics include quinolones, cephalosporins, and nitrofurantoin. However, long-term use is associated with significant limitations, such as antimicrobial resistance, disruption of the microbiome, and adverse effects including gastrointestinal disturbances and fungal infections.

In specific cases, additional interventions are applied:

• Topical estrogen therapy in postmenopausal women, aiming to restore normal flora and epithelial integrity.
• Analgesics and antispasmodics for symptom relief, especially in severe dysuria.
• Urinary antiseptics, used adjunctively to reduce microbial load.

Despite their effectiveness in symptom management, conventional treatments do not always address the underlying causes, leading to frequent recurrences.

(b) Natural therapies

Nutrition
Diet is a fundamental pillar in the prevention and management of chronic UTI. Consumption of antioxidant-rich foods such as fruits and vegetables helps reduce inflammation and strengthen the immune system. Adequate hydration is particularly important, as increased fluid intake helps flush bacteria from the urinary tract. Avoiding excessive sugar and processed foods is essential, as these promote microbial growth and dysbiosis. Additionally, increasing probiotic intake through foods such as yogurt and fermented products may help restore normal microbiota.

Lifestyle
Lifestyle directly influences immune function and susceptibility to infections. Adequate sleep quality, regular physical activity, and stress management are essential factors for maintaining health. Proper hygiene of the genital area, without excessive use of antiseptic products that disrupt natural flora, is also important. Additionally, urination after sexual intercourse and avoiding delaying urination are recommended practices that reduce bacterial growth risk.

Dietary supplements
Certain supplements have been studied for their role in prevention and supportive therapy:

• D-mannose: A natural sugar that prevents Escherichia coli from adhering to the urothelium. Typically administered at doses of 1.5–2 grams daily, with good tolerance and minimal side effects.
• Cranberry extract: Contains proanthocyanidins that inhibit bacterial adhesion. Its use is more effective as a preventive measure.
• Probiotics (Lactobacillus spp.): Help restore normal flora and reduce recurrence. Intake should be consistent and long-term.
• Vitamin D: Regulates immune response, and deficiency is associated with increased infection risk. Dosage should be individualized based on laboratory values.
   

Herbal therapies
Some herbal extracts exhibit antimicrobial and anti-inflammatory properties:

• Bearberry (Arctostaphylos uva-ursi): Contains arbutin, which is converted into hydroquinone with antiseptic action in the urinary tract. Use should be short-term and cautious in individuals with liver conditions.
• Garlic extract: Exhibits broad-spectrum antimicrobial activity and may be used as adjunct therapy.
• Berberine: A plant alkaloid with antibacterial properties, useful in cases of dysbiosis.

The use of supplements and herbal preparations should be guided by a healthcare professional, especially in individuals taking medications or with underlying health conditions.

References

1. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015 May;13(5):269-84. doi: 10.1038/nrmicro3432. Epub 2015 Apr 8. PMID: 25853778; PMCID: PMC4457377.
2. Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019 May 2;11:1756287219832172. doi: 10.1177/1756287219832172. PMID: 31105774; PMCID: PMC6502976.
3. Anger J, Lee U, Ackerman AL, Chou R, Chughtai B, Clemens JQ, Hickling D, Kapoor A, Kenton KS, Kaufman MR, Rondanina MA, Stapleton A, Stothers L, Chai TC. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. J Urol. 2019 Aug;202(2):282-289. doi: 10.1097/JU.0000000000000296. Epub 2019 Jul 8. Update in: J Urol. 2022 Oct;208(4):754-756. doi: 10.1097/JU.0000000000002888. PMID: 31042112.
4. Stapleton A. Prevention of recurrent urinary-tract infections in women. Lancet. 1999 Jan 2;353(9146):7-8. doi: 10.1016/S0140-6736(05)74875-3. PMID: 10023942.
5. Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 2015 Dec 23;2015(12):CD008772. doi: 10.1002/14651858.CD008772.pub2. PMID: 26695595; PMCID: PMC8720415.
6. Lenger SM, Bradley MS, Thomas DA, Bertolet MH, Lowder JL, Sutcliffe S. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020 Aug;223(2):265.e1-265.e13. doi: 10.1016/j.ajog.2020.05.048. Epub 2020 Jun 1. PMID: 32497610; PMCID: PMC7395894.
7. Storme O, Tirán Saucedo J, Garcia-Mora A, Dehesa-Dávila M, Naber KG. Risk factors and predisposing conditions for urinary tract infection. Ther Adv Urol. 2019 May 2;11:1756287218814382. doi: 10.1177/1756287218814382. PMID: 31105772; PMCID: PMC6502981.
8. Wagenlehner FME et al. (2020). Recurrent urinary tract infections. Current Opinion in Urology.
9. Beerepoot MA, Geerlings SE, van Haarst EP, van Charante NM, ter Riet G. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013 Dec;190(6):1981-9. doi: 10.1016/j.juro.2013.04.142. Epub 2013 Jul 15. PMID: 23867306.